Rezolute Statistics
NASDAQ: RZLTHealth CareBiotechnology: Pharmaceutical PreparationsUSD
4.88+0.235 (+5.06%)
Market open · Delayed 15 min · as of Oct 9, 1:52 PM ET
Rezolute by the numbers
Rezolute has a market capitalization of $471.5 million based on 96.72M shares outstanding. With trailing EPS of $-0.75, Rezolute is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 9.3% above its 50-day average and 29.9% above its 200-day average.
Average daily trading volume is 1.50M shares, or about $7.3 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
RZLT valuation vs. peer median
| Metric | RZLT | Peer median | Difference |
|---|---|---|---|
| Market cap | $471.52M | $458.72M | +3% |
| Avg. volume | 1.50M | 391.74K | +282% |
Peer median across 8 companies: CAPR, DMAC, KMDA, PRTA, SPRY, OVID, ASMB, AVIR.
Valuation
- Market cap
- $471.52M
- EPS (TTM)
- $-0.75
- Shares outstanding
- 96.72M
Price and trading
- Previous close
- 4.64
- Open
- 4.60
- Day range
- 4.55 – 4.91
- 52-week range
- 1.07 – 11.46
- 52-week change
- -46.79%
- Beta
- —
- Volume
- 1.17M
- Average volume
- 1.50M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 471.52M
- Forward Pe
- -10.40
- Eps
- -0.75
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 11.46
- Week52 Low
- 1.07
- Avg Volume
- 1.50M
- Shares Outstanding
- 96.72M
- Ma50
- 4.46
- Ma200
- 3.75
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -57.45%
- Pct From52w Low
- 355.61%